Phase I clinical trials

Our Phase I unit offers a fully integrated environment for early-stage clinical research — bringing together clinical facility, bioanalytical laboratory, and data management under one roof. This streamlined setup shortens timelines, reduces risks, and ensures seamless coordination from study design to final report.

We conduct a wide range of Phase I studies, tailored to your compound’s development needs, including:

✓ First-In-Human (FIH) Studies — Single-Ascending Dose (SAD) and Multiple-Ascending Dose (MAD)
✓ Food-Effect Studies
✓ Dose Escalation Studies
✓ Drug-Drug Interaction Studies
✓ Bioavailability / Bioequivalence (BA/BE) Studies
✓ Steady-State Studies
✓ Biosimilarity Studies

With all processes — from protocol creation to archiving — handled on-site, we provide unmatched oversight and quality assurance at every stage.